Advertisement
Sigma-Aldrich
Sigma-Aldrich

The Nutshell

Daily News Roundup

Most Recent

image: Nemeroff Appointment Protested

Nemeroff Appointment Protested

By | April 4, 2012

A psychiatric professional society is getting heat over its decision to add a scientist accused of repeated conflicts of interest to its advisory board.

0 Comments

image: Poisonous Shrooms Battle Cancer

Poisonous Shrooms Battle Cancer

By | April 4, 2012

A deadly mushroom toxin shrinks pancreatic tumors in mice.

2 Comments

image: How Predictive are Genomes?

How Predictive are Genomes?

By | April 3, 2012

Researchers put the predictive power of whole genome sequencing to the test.

2 Comments

image: US Doesn’t Ban BPA

US Doesn’t Ban BPA

By | April 2, 2012

The FDA announces that BPA will continue to be permitted in food and beverage containers.

4 Comments

image: Bird Flu Papers to Publish

Bird Flu Papers to Publish

By | April 2, 2012

Biosecurity board recommends publication of data detailing transmissibility of H5N1 avian influenza.

4 Comments

image: Obesity Drugs in Check

Obesity Drugs in Check

By | April 2, 2012

The FDA may require weight-loss drugs to undergo clinical trials to see if they pose a risk of heart attack.

2 Comments

image: Big Money for Big Data

Big Money for Big Data

By | April 2, 2012

The Obama administration pledges $200 million for better ways of managing and extracting information from large data sets.

0 Comments

image: Risky Research Review

Risky Research Review

By | March 30, 2012

A new policy will require federal agencies to perform a careful review of research involving 15 pathogens and toxins that could be used for bioterrorism, including H5N1.

2 Comments

image: Pesticide Problems for Bees

Pesticide Problems for Bees

By | March 30, 2012

Bees exposed to neonicotinoids, a widely-used class of pesticide, navigate poorly and produce fewer queens, suggesting a role for neonicotinoids in colony collapse.

0 Comments

image: Failed Drugs Expose Preclinical Blunders

Failed Drugs Expose Preclinical Blunders

By | March 30, 2012

Once a promising cancer treatment, the failure of PARP inhibitors in the clinic may be due to flawed preclinical studies.

2 Comments

Advertisement
Horizon Discovery
Horizon Discovery

Popular Now

  1. Antibody Alternatives
    Features Antibody Alternatives

    Nucleic acid aptamers and protein scaffolds could change the way researchers study biological processes and treat disease.

  2. The Mycobiome
    Features The Mycobiome

    The largely overlooked resident fungal community plays a critical role in human health and disease.

  3. Circadian Clock and Aging
    Daily News Circadian Clock and Aging

    Whether a critical circadian clock gene is deleted before or after birth impacts the observed aging-related effects in mice.

  4. Biologist Resigns Amid Sexual Misconduct Probe
Advertisement
Advertisement
Life Technologies